|
| | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide Basic information | | Uses |
| Product Name: | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide | | Synonyms: | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide;1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide;4-hydroxy-7-methoxyquinoline-6-carboxamide;phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-;lenvaim-C;Lenvatinib Impurity 19;6-Quinolinecarboxamide, 1,4-dihydro-7-methoxy-4-oxo-;7-methoxy-4-oxo-1,4-dihydro-6-quinolinecarboxamide | | CAS: | 417724-81-3 | | MF: | C11H10N2O3 | | MW: | 218.21 | | EINECS: | | | Product Categories: | | | Mol File: | 417724-81-3.mol |  |
| | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide Chemical Properties |
| Boiling point | 372.1±42.0 °C(Predicted) | | density | 1.324±0.06 g/cm3(Predicted) | | pka | 15.36±0.20(Predicted) |
| | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide Usage And Synthesis |
| Uses | 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide is a metabolite of Lenvatinib which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. | | Uses | 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. |
| | 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide Preparation Products And Raw materials |
|
